Catecholaminergic polymorphic ventricular tachycardia: Recent mechanistic insights

Cardiovascular Research

Volumn 67, Issue 3, 2005, Pages 379-387

  Kontula, Kimmo ^a   Laitinen, Päivi J ^a   Lehtonen, Annukka ^a   Toivonen, Lauri ^a   Viitasalo, Matti ^a   Swan, Heikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Ca channel; E c coupling; SR function; Sudden death; Ventricular arrhythmias

Indexed keywords

4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CALSEQUESTRIN; CATECHOLAMINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DILTIAZEM; ION; MAGNESIUM SULFATE; MEXILETINE; NADOLOL; PROPRANOLOL; REGULATOR PROTEIN; RYANODINE RECEPTOR; VERAPAMIL;

ACTION POTENTIAL; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE DISORDER; BASEMENT MEMBRANE; CALCIUM TRANSPORT; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CYTOSOL; DEFIBRILLATOR; DRUG EFFICACY; DRUG RECEPTOR BINDING; EMOTIONAL STRESS; ENZYME PHOSPHORYLATION; EXCITATION CONTRACTION COUPLING; EXERCISE; GENE MUTATION; HEART DISEASE; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; INHERITANCE; ISCHEMIA; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; MOLECULE; MORTALITY; ONSET AGE; PATHOGENESIS; PHYSICAL STRESS; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SUDDEN DEATH; SYNCOPE; TREATMENT FAILURE;

ANIMALS; CALCIUM CHANNELS; CALCIUM SIGNALING; CALSEQUESTRIN; DEATH, SUDDEN, CARDIAC; HUMANS; POLYMORPHISM, GENETIC; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; TACHYCARDIA, VENTRICULAR;

EID: 22544446205     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.04.027     Document Type: Review

References (51)

1. A. Leenhardt, V. Lucet, I. Denjoy, F. Grau, D.D. Ngoc, and P. Coumel Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients Circulation 91 1995 1512 1519
2. J.D. Fisher, D. Krikler, and K.A. Hallidie-Smith Familial polymorphic ventricular arrhythmias. A quarter century of successful medical treatment based on serial exercise-pharmacologic testing J Am Coll Cardiol 43 1999 2015 2022
3. H. Swan, K. Piippo, M. Viitasalo, P. Heikkilä, K. Paavonen, and K. Kainulainen Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts J Am Coll Cardiol 34 1999 2035 2042
4. P.J. Laitinen, K.M. Brown, K. Piippo, H. Swan, J.M. Devaney, and B. Brahmbhatt Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia Circulation 103 2001 485 490
5. S.G. Priori, C. Napolitano, N. Tiso, M. Memmi, G. Vignati, and R. Bloise Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 103 2001 196 200
6. H. Lahat, M. Eldar, E. Levy-Nissenbaum, T. Bahan, E. Friedman, and A. Khoury Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia. Clinical features and assignment of the disease gene to chromosome 1p13-21 Circulation 103 2001 2822 2827
7. A.V. Postma, I. Denjoy, T.M. Hoorntje, J.-M. Lupoglazoff, A. Da Costa, and P. Sebillon Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia Circ Res 91 2002 21 26
8. B. Bauce, A. Rampazzo, C. Basso, A. Bagattin, L. Daliento, and N. Tiso Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death J Am Coll Cardiol 40 2002 341 349
9. S.G. Priori, C. Napolitano, M. Memmi, B. Colombi, F. Drago, and M. Gasparini Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia Circulation 106 2002 69 74
10. X.H.T. Wehrens, S.E. Lehnart, F. Huang, J.A. Vest, S.R. Reiken, and P.J. Mohler FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death Cell 113 2003 829 840
11. S.E. Lehnart, X.H.T. Wehrens, P.J. Laitinen, S.R. Reiken, S.-X. Deng, and Z. Cheng Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak Circulation 109 2004 3208 3214
12. G. Choi, L.J. Kopplin, D.J. Tester, M.L. Will, C.M. Haglund, and M.J. Ackerman Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes Circulation 110 2004 2119 2124
13. N. Tiso, D.A. Stephan, A. Nava, A. Bagattin, J.M. Devaney, and F. Stanchi Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2) Hum Mol Genet 10 2001 189 194
14. P.J. Laitinen, H. Swan, and K. Kontula Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphism Eur J Hum Genet 11 2003 888 891
15. A. Bagattin, C. Veronese, B. Bauce, W. Wuyts, L. Settimo, and A. Nava Denaturing HPLC-based approach for detecting RYR2 mutations involved in malignant arrhythmias Clin Chem 50 2004 1148 1155
16. C. Hasdemir, S.G. Priori, E. Overholt, and R. Lazzara Catecholaminergic polymorphic ventricular tachycardia, recurrent syncope, and implantable loop recorder J Cardiovasc Electrophysiol 15 2004 729
17. D.J. Tester, D.B. Spoon, H.H. Valdivia, J.C. Makielski, and M.J. Ackerman Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases Mayo Clin Proc 79 2004 1380 1384
18. A.V. Postma, Z.A. Bhuiyan, M. Shkolnikova, I. Denjoy, M.M.A.M. Mannens, and A.A.M. Wilde Involvement of the Kir2 gene family in catecholaminergic polymorphic ventricular tachycardia; analysis for mutations and identification of numerous pseudogenes Eur Heart J 25 2004 66
19. H. Lahat, E. Pras, T. Olender, N. Avidan, E. Ben-Asher, and O. Man A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel Am J Hum Genet 69 2001 1378 1384
20. H. Takeshima, S. Komazaki, K. Hirose, M. Nishi, T. Noda, and M. Iino Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2 EMBO J 17 1998 3309 3316
21. X.H.T. Wehrens, and A.R. Marks Altered function and regulation of cardiac ryanodine receptors in cardiac disease Trends Biochem Sci 28 2003 671 678
22. S.E. Lehnart, X.H.T. Wehrens, and A.R. Marks Calstabin deficiency, ryanodine receptors, and sudden cardiac death Biochem Biophys Res Commun 322 2004 1267 1279
23. S.E. Lehnart, X.H.T. Wehrens, A. Kushnir, and A.R. Marks Cardiac ryanodine receptor function and regulation in heart disease Ann N Y Acad Sci 1015 2004 144 159
24. X.H.T. Wehrens, S.E. Lehnart, and A.R. Marks Intracellular calcium release channels and cardiac disease Annu Rev Physiol 67 2005 69 98
25. S.O. Marx, S. Reiken, Y. Hisamatsu, T. Jayaraman, D. Burkhoff, and N. Rosemblit PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts Cell 101 2000 365 376
26. S. Reiken, M. Gaburjakova, J. Gaburjakova, K.-I. He, A. Prieto, and E. Becker β-adrenergic blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure Circulation 104 2001 2843 2848
27. S. Reiken, X.H.T. Wehrens, J.A. Vest, A. Barbone, S. Klotz, and D. Mancini β-blockers restore calcium release function and improve cardiac muscle performance in human heart failure Circulation 107 2003 2459 2466
28. 2+/Calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor Circ Res 94 2004 e61 e70
29. M. Yano, S. Kobayashi, M. Kohno, M. Doi, T. Tokuhisa, and S. Okuda FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure Circulation 107 2003 477 484
30. X.H.T. Wehrens, S.E. Lehnart, S.R. Reiken, S.-X. Deng, J.A. Vest, and D. Cervantes Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2 Science 304 2004 292 296
31. 2+ release, but normal ryanodine receptors, in canine and human heart failure Circ Res 91 2002 1015 1022
32. Y. Li, E.G. Kranias, G.A. Mignery, and D.M. Bers Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes Circ Res 90 2002 309 316
33. N. Tiso, M. Salamon, A. Bagattin, G.A. Danieli, F. Argenton, and M. Bortolussi The binding of the RyR2 calcium channel to its gating protein FKBP12.6 is oppositely affected by ARVD2 and VTSIP mutations Biochem Biophys Res Commun 299 2002 594 598
34. N.L. Thomas, C.H. George, and F.A. Lai Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death Cardiovasc Res 64 2004 52 60
35. C.H. George, G.V. Higgs, and F.A. Lai Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increase calcium release in stimulated cardiomyocytes Circ Res 93 2003 531 540
36. P.D. Allen Not all sudden death is the same Circ Res 93 2003 484 486
37. 2+-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6) Circ Res 94 2004 487 495
38. 2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death Circ Res 91 2002 218 225
39. 2+ release (SOICR) Proc Natl Acad Sci U S A 101 2004 13062 13067
40. K. Yano, and A. Zarain-Herzberg Sarcoplasmic reticulum calsequestrins: structural and functional properties Mol Cell Biochem 135 1994 61 70
41. 2+ signaling in transgenic cardiac myocytes overexpressing calsequestrin J Clin Invest 101 1998 1385 1393
42. Y. Sato, D.F. Ferguson, H. Sako, G.W. Dorn, V.J. Kadambi, and A. Yatani Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice J Biol Chem 273 1998 28470 28477
43. 2+ release in cardiac myocytes Circ Res 91 2002 414 420
44. D. Terentyev, S. Viatchenko-Karpinski, I. Györke, P. Volpe, S.C. Williams, and S. Györke Calsequestrin determines the cardiac intracellular cacium stores: mechanism for hereditary arrhythmia Proc Natl Acad Sci U S A 100 2003 11759 11764
45. S. Viatchenko-Karpinski, D. Terentyev, I. Györke, R. Terentyeva, P. Volpe, and S.G. Priori Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin Circ Res 94 2004 471 477
46. T.D. Houle, M.L. Ram, and S.E. Cala Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium Cardiovasc Res 64 2004 227 233
47. N. Sumitomo, K. Harada, M. Nagashima, T. Yasuda, Y. Nakamura, and Y. Aragaki Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death Heart 89 2003 66 70
48. G. De Rosa, A.B. Delogu, M. Piastra, A. Chiaretti, R. Bloise, and S.G. Priori Catecholaminergic polymorphic ventricular tachycardia. Successful emergency treatment with intravenous propranolol Pediatr Emerg Care 20 2004 175 177
49. H.H. Valdivia, C. Valdivia, J. Ma, and R. Coronado Direct binding of verepamil to the ryanodine receptor channel of sarcoplasmic reticulum Biophys J 58 1990 471 481
50. H. Swan, P. Laitinen, K. Kontula, and L. Toivonen Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations J Cardiovasc Electrophysiol 16 2005 162 166
51. v 1.2 channel dysfunction causes a multisystem disorder including arrhythmia and autism Cell 119 2004 19 31